Kwang Dong Pharmaceutical Co., Ltd. (009290.KS)
009290.KS Stock Price Chart
Explore Kwang Dong Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 009290.KS price movements and trends.
009290.KS Company Profile
Discover essential business fundamentals and corporate details for Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
1.04K
Website
https://www.ekdp.comCEO
Sung-Won Choi
Description
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods. In addition, it engages in the operation of hospitals; and the retail and wholesale of products through discount stores, TV home shopping, and Internet shopping malls. Further, the company operates as a MRO total service provider for the raw/intermediate materials and consumables under various business models, such as the construction purchase service and overseas local purchase service. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.
009290.KS Financial Timeline
Browse a chronological timeline of Kwang Dong Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at ₩63.54 , while revenue for the quarter reached ₩425.29B .
Earnings released on 13 May 2025
EPS came in at ₩95.00 , while revenue for the quarter reached ₩377.60B .
Dividend declared on 31 Mar 2025
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 23 Apr 2025.
Earnings released on 24 Feb 2025
EPS came in at ₩304.27 , while revenue for the quarter reached ₩390.83B .
Earnings released on 14 Nov 2024
EPS came in at ₩220.00 , while revenue for the quarter reached ₩424.59B , beating expectations by +35.19K%.
Earnings released on 12 Aug 2024
EPS came in at ₩33.01 , while revenue for the quarter reached ₩412.81B , beating expectations by +34.21K%.
Earnings released on 13 May 2024
EPS came in at ₩454.09 , while revenue for the quarter reached ₩412.49B , beating expectations by +34.18K%.
Earnings released on 26 Mar 2024
EPS came in at ₩138.05 , while revenue for the quarter reached ₩384.31B , beating expectations by +58.15%.
Dividend declared on 27 Dec 2023
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 25 Apr 2024.
Earnings released on 11 Nov 2023
EPS came in at ₩220.32 , while revenue for the quarter reached ₩397.84B .
Earnings released on 11 Aug 2023
EPS came in at ₩210.48 , while revenue for the quarter reached ₩375.36B .
Earnings released on 12 May 2023
EPS came in at ₩341.87 , while revenue for the quarter reached ₩356.95B , beating expectations by +29.56K%.
Earnings released on 16 Mar 2023
EPS came in at ₩173.95 , while revenue for the quarter reached ₩379.84B , beating expectations by +31.47K%.
Dividend declared on 28 Dec 2022
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 20 Apr 2023.
Earnings released on 30 Sept 2022
EPS came in at ₩156.79 , while revenue for the quarter reached ₩377.65B .
Earnings released on 30 Jun 2022
EPS came in at ₩73.03 , while revenue for the quarter reached ₩361.81B .
Earnings released on 31 Mar 2022
EPS came in at ₩184.68 , while revenue for the quarter reached ₩312.25B .
Earnings released on 14 Feb 2022
EPS came in at ₩160.61 , while revenue for the quarter reached ₩360.77B .
Dividend declared on 29 Dec 2021
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 19 Apr 2022.
Earnings released on 15 Nov 2021
EPS came in at ₩57.00 , while revenue for the quarter reached ₩332.84B .
Earnings released on 30 Sept 2021
EPS came in at ₩217.00 , while revenue for the quarter reached ₩350.43B .
Earnings released on 31 Mar 2021
EPS came in at ₩150.00 , while revenue for the quarter reached ₩294.14B .
Earnings released on 15 Feb 2021
EPS came in at -₩165.29 , while revenue for the quarter reached ₩304.64B .
Dividend declared on 29 Dec 2020
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 20 Apr 2021.
Earnings released on 16 Nov 2020
EPS came in at ₩742.00 , while revenue for the quarter reached ₩315.87B .
009290.KS Stock Performance
Access detailed 009290.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.